Cumberland Pharmaceuticals CPIX Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's other non-current liabilities?
- Cumberland Pharmaceuticals (CPIX) reported other non-current liabilities of $5.62M in Q1 2026.
- How has Cumberland Pharmaceuticals's other non-current liabilities changed year-over-year?
- Cumberland Pharmaceuticals's other non-current liabilities decreased by 6.4% year-over-year, from $6.01M to $5.62M.
- What is the long-term trend for Cumberland Pharmaceuticals's other non-current liabilities?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's other non-current liabilities has grown at a -5.8% compound annual growth rate (CAGR), from $7.86M to $5.82M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.